Lung Cancers Completed Phase 3 Trials for Etoposide (DB00773)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00045162S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung CancerTreatment
NCT00660504Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung CancerTreatment
NCT00433498Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung CancerTreatment
NCT00061919Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung CancerTreatment
NCT00041015Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00002550Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerTreatment
NCT00002823Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung CancerTreatment
NCT00002822Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung CancerTreatment
NCT00003299Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00003364Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung CancerTreatment
NCT01134861Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerTreatment